Whether nuclear localization of ErbB receptors affects their availability and/or ability to bind NRG-1 ligands and thereby contribute to the obliteration of compensatory NRG-1/ErbB signaling in the diabetic heart after MI is equally important from a therapeutic standpoint and warrants further investigation. Here, EGFR is linked to myocardial infarction.